Compumedics (ASX:CMP) — Material Events

ASX:CMP · 7 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 7 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
7
Compumedics Accelerates Somfit D Rollout After Early FDA NodMedium
Compumedics raises $2.15M to accelerate Somfit D commercialisation after early FDA approval
15 Oct 2025 ·Capital Raising ·85
Compumedics Surges with 32% Revenue Growth and Returns to Profit in H1 FY26Medium
Compumedics posts 32% revenue growth and returns to profit in H1 FY26, driven by MEG and SaaS expansion
25 Feb 2026 ·Half-year financial report ·85
Compumedics Posts Record H1 Sales Orders, Eyes Stronger H2 with Somfit D LaunchMedium
Compumedics posts record H1 FY26 sales orders and 32% revenue growth, reaffirms FY26 guidance
22 Jan 2026 ·Business Update ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.